78 related articles for article (PubMed ID: 15153313)
1. Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications.
Zardi EM; Picardi A; Fazio VM; Ambrosino G; Dobrina A; Zullo M; Zennaro D; Afeltra A
J Interferon Cytokine Res; 2004 May; 24(5):297-300. PubMed ID: 15153313
[TBL] [Abstract][Full Text] [Related]
2. Enhanced portal flow velocity and volume following Iloprost treatment.
Zardi EM; Picardi A; Ambrosino G; Fazio VM; Dobrina A; Afeltra A; Frego M
Acta Biomed; 2003; 74 Suppl 2():108-10. PubMed ID: 15055047
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of a prostacyclin analog (iloprost) on portal flow velocity and volume and visceral artery circulation in patients with lower limb arteriopathy.
Zardi EM; Picardi A; Ambrosino G; Serio A; Costantino S; Dobrina A
Ultrasound Med Biol; 2003 Feb; 29(2):209-13. PubMed ID: 12659908
[TBL] [Abstract][Full Text] [Related]
4. Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis.
Zardi EM; Picardi A; Ambrosino G; Fazio VM; Dobrina A; Frego M; Afeltra A; Lumachi F
In Vivo; 2006; 20(3):377-80. PubMed ID: 16724674
[TBL] [Abstract][Full Text] [Related]
5. Iloprost: an adjunctive approach to chronic viral hepatitis treatment.
Zardi EM; Vespasiani Gentilucci U; Picardi A; Ambrosino G; Fazio VM; Dobrina A; Afeltra A
Med Hypotheses; 2005; 64(1):46-52. PubMed ID: 15533610
[TBL] [Abstract][Full Text] [Related]
6. N-acetylcysteine infusion improves hepatic perfusion in the early stages of systemic sclerosis.
Rosato E; Zardi EM; Barbano B; Menghi G; Cianci R; Amoroso A; Afeltra A; Pisarri S; Salsano F
Int J Immunopathol Pharmacol; 2009; 22(3):763-72. PubMed ID: 19822093
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive assessment of liver steatosis, fibrosis and inflammation in chronic hepatitis C virus infection.
Schneider AR; Teuber G; Kriener S; Caspary WF
Liver Int; 2005 Dec; 25(6):1150-5. PubMed ID: 16343065
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of necrotizing vasculitic lesions after infusion of iloprost in a patient with cryoglobulinemia and chronic HCV infection.
Lo Gullo R; De Filippis L; Caliri A; Bagnato G
Clin Exp Rheumatol; 2005; 23(6):912-3. PubMed ID: 16396716
[No Abstract] [Full Text] [Related]
9. Hemodynamic effects of a prostacyclin analog (Prostavasin) in systemic scleroderma patients.
Salera D; Argalia G; Giuseppetti GM
Radiol Med; 2005; 110(1-2):106-14. PubMed ID: 16163145
[TBL] [Abstract][Full Text] [Related]
10. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbruck B; Grimminger F; Seeger W
Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735
[TBL] [Abstract][Full Text] [Related]
11. Opposite effects of prostacyclin on hepatic blood flow and oxygen consumption after burn and sepsis.
Tadros T; Traber DL; Herndon DN
Ann Surg; 2004 Jan; 239(1):67-74. PubMed ID: 14685102
[TBL] [Abstract][Full Text] [Related]
12. Hepatic and portal vein flow pattern in correlation with intrahepatic fat deposition and liver histology in patients with chronic hepatitis C.
Dietrich CF; Lee JH; Gottschalk R; Herrmann G; Sarrazin C; Caspary WF; Zeuzem S
AJR Am J Roentgenol; 1998 Aug; 171(2):437-43. PubMed ID: 9694471
[TBL] [Abstract][Full Text] [Related]
13. Intravenous iloprost bridging to orthotopic liver transplantation in portopulmonary hypertension.
Minder S; Fischler M; Muellhaupt B; Zalunardo MP; Jenni R; Clavien PA; Speich R
Eur Respir J; 2004 Oct; 24(4):703-7. PubMed ID: 15459152
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus reinfection in liver transplant patients: evaluation of liver damage progression with echo-color Doppler.
Bolognesi M; Quaglio C; Bombonato G; Guido M; Cavalletto L; Chemello L; Merkel C; Rugge M; Gatta A; Sacerdoti D
Liver Transpl; 2008 May; 14(5):616-24. PubMed ID: 18324620
[TBL] [Abstract][Full Text] [Related]
15. Six years' experience with prostaglandin I2 infusion in elective open repair of abdominal aortic aneurysm: a parallel group observational study in a tertiary referral vascular center.
Beirne C; Hynes N; Sultan S
Ann Vasc Surg; 2008 Nov; 22(6):750-5. PubMed ID: 18992665
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of vasodilator effects of iloprost versus diltiazem on flow and pathologic changes in radial arteries: mid-term angiographic control study of the comparison of vasodilators on radial artery vasospasm.
Ustunsoy H; Kazaz H; Celkan MA; Deniz H; Davutoglu V; Bakir K; Cine N; Burma O
Heart Surg Forum; 2009 Aug; 12(4):E202-7. PubMed ID: 19683989
[TBL] [Abstract][Full Text] [Related]
17. Doppler sonography measurement of portal blood flow velocity after glucagon injection in patients with chronic HCV infection.
Sereno S; Toccaceli F; Russo V; Iacomi F; Zardi EM; Laghi V
Ultrasound Med Biol; 2001 May; 27(5):723-6. PubMed ID: 11397536
[TBL] [Abstract][Full Text] [Related]
18. First experiences with the stable prostacyclin analog iloprost in the evaluation of heart transplant candidates with increased pulmonary vascular resistance.
Sablotzki A; Czeslick E; Gruenig E; Friedrich I; Schubert S; Börgermann J; Hentschel T
J Thorac Cardiovasc Surg; 2003 Apr; 125(4):960-2. PubMed ID: 12698166
[No Abstract] [Full Text] [Related]
19. Clinical and circulatory effects of Iloprost either administered for 1 week or 4 weeks in patients with peripheral obstructive arterial disease at Leriche-Fontaine stage III.
Arosio E; Sardina M; Prior M; De Marchi S; Zannoni M; Bianchini C
Eur Rev Med Pharmacol Sci; 1998; 2(2):53-9. PubMed ID: 10229559
[TBL] [Abstract][Full Text] [Related]
20. Letter to the editor: Kratzer W et al. Prevalence and risk factors of focal sparing in hepatic steatosis. Ultraschall in Med 2010; 31: 37 - 42.
Dietrich CF
Ultraschall Med; 2010 Aug; 31(4):417-9. PubMed ID: 20703973
[No Abstract] [Full Text] [Related]
[Next] [New Search]
